Read More Healthcare Industry News Why Hester Biosciences’ trading window closure matters for investors chasing momentum in NSE: HESTERBIO Hester Biosciences (NSE: HESTERBIO) has closed its trading window ahead of Q2 results. At ₹1,920 and 47x P/E, can the stock sustain its premium? byPallavi MadhirajuSeptember 29, 2025